Helping to share the web since 1996
Therapeutic peptides and proteins as HIV-1 inhibitors have many advantages, such as high specificity and affinity to their molecular targets, and HIV-1 mutants are difficult to avoid these molecules, and are gradually becoming an alternative strategy
There are no posts for this page yet.
Upgrade Options